靶向BRCA缺陷肿瘤的新颖Polθ抑制剂 (IMAGE) InSilico Medicine Caption 在Chemistry42平台支持下,研究团队采用基于配体和基于结构的药物设计(LBDD & SBDD)策略,针对目标靶点Polθ成功精准生成分子系列母核。 Credit 英矽智能 Usage Restrictions none License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.